Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-24 @ 3:27 PM
NCT ID:
NCT03082092
Eligibility Criteria:
Inclusion Criteria:
* Elective unilateral total knee replacement for primary osteoarthritis of knee
* ASA (American Society of Anesthesiologists) grading 1 or 2
Exclusion Criteria:
* Rheumatoid arthritis or seronegative arthritis
* Allergy to any medications used in the standard protocol (Methylprednisolone, adrenaline, ropivacaine, ketorolac, bupivacaine, ketorolac, pepcidine, transamin, gabapentin, voltaren, panadol, DF118)
* Chronic opioid use
* Substance dependence
* Patients attending chronic pain clinic
* Psychiatric or neurological condition that may influence pain perception or reporting
* Chronic illness that preclude the use of the medications in the standard protocol
* Hepatitis B carrier or Elevated bilirubin or ALT
* Active peptic ulcer disease
* Uncontrolled diabetic patients with HbA1c \>7% in recent 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03082092
Study Brief:
Protocol Section:
NCT03082092